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Abstract: 
Upper gastrointestinal bleeding (UGIB) represents a substantial clinical and economic burden with 
significant mortality and morbidity. Validated prognostic scales are used to stratify patients into low and 
high risk, on the basis of clinical, laboratory, and endoscopic criteria. Early identiﬁcation of high-risk 
patients allows appropriate intervention, which minimizes morbidity and mortality. 
 
Background: 
Acute upper gastrointestinal bleeding is the commonest emergency managed by gastroenterologists. It 
represents a substantial clinical and economic burden, with reported incidence ranging from 48 to 160 
cases per 100 000adults per year (1)   and mortality generally from 10% to14%. (2) The incidence being 
highest in areas of the lowest socioeconomic status. Most deaths occur in elderly patients who have 
significant comorbidity and the majorities are inevitable, despite improvements in medical and surgical 
expertise. Mortality is reported to be lower in specialist units (3) and this is probably not related to 
technical developments but because of adherence to protocols and guidelines. 
Although a proportion of patients presenting with UGIH require transfusion, endoscopic or surgical 
intervention and a small minority die, the majority do not require intervention and remain well. Similar to 
other common medical conditions including chest pain, deep venous thrombosis and chest infection, risk-
scoring systems for UGIH have been developed. 
Scoring systems in clinical practice   
Current risk-stratification systems for patients with acute upper-gastrointestinal bleeding discriminate 
between patients at high or low risks of dying or rebleeding. 
Many scoring systems have been developed to direct appropriate patient management of upper GI 
bleeding, predict the risk of rebleeding or death in patients with upper gastrointestinal bleeding and 
enable cost effective use of resources. The most widely used score is the Rockall score (Table 1).This was 
developed by Rockall et al in 1996 (4). The Rockall score was designed to predict mortality used the data 
from an audit in four English Health regions, but Rockall et al suggested that it could also be used for the 
prediction of re-bleeding (5).  
The Rockall score is a prognostic score based on the patient's age, presence of shock, coexisting illness, 
diagnosis, and stigmata of hemorrhage. Therefore, before the Rockall score can be calculated, the 
endoscopy must first be performed. Patients with a score of 2 or below are at low risk of rebleeding and 
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death. Although one validation study found the prediction of risk of rebleeding to be unsatisfactory with 
the Rockall score, another large retrospective study found the score useful in influencing the management 
of patients based on their severity of illness..(6) (7) An abbreviated ‘admission’ Rockall score (excluding 
the two endoscopic criteria) has been used in some centres, but this has never been fully validated. 
 
Table 1: The Rockall Score 
Component 
score 0 1 2 3 
Age (years) <60 60–79 ≥80 – 
Shock 
     Pulse (bpm) <100 ≥100 – – 
 Systolic BP 
(mmHg) ≥100 ≥100 <100 – 
Co-morbidity None – 
IHD, cardiac failure, other 
major co-morbidity 
Renal or liver failure, 
disseminated 
malignancy 
Diagnosis 
MW or no lesion 
and no stigmata 
All other 
diagnoses Malignant lesions of UGIT – 
Stigmata of 
haemorrhage 
No stigmata or 
dark spot on 
ulcer – 
Blood in UGIT, adherent 
clot, visible/spurting vessel – 
UGIT, upper gastrointestinal tract; BP, blood pressure; IHD, ischaemic heart disease 
 
Although most risk scoring systems for this disorder incorporate endoscopic findings, the Glasgow-
Blatchford bleeding score (GBS) is based on simple clinical and laboratory variables; a score of 0 
identifies low-risk patients who might be suitable for outpatient management..  
The Glasgow-Blatchford score (Table 2)  was developed in 2000 (6) to predict a patient’s risk of 
requiring intervention or death It can be calculated by tallying up the points for each of the following 
criteria: systolic blood pressure, blood urea nitrogen, hemoglobin, and the presence of tachycardia, 
melena, syncope, liver, or cardiac diseases.  High scores carry a graver prognosis and require 
intervention, as compared with lower scores. One advantage of this score is that it can be calculated when 
the patient presents to the physician. Unlike the Rockall score, both endoscopy and the diagnosis are not 
required for the Glasgow-Blatchford score. The Glasgow-Blatchford score has been used successfully to 
stratify patients into different risk groups. Those with low scores can be managed outpatient, whereas 
those with higher scores are admitted and treated in hospital. The GBS has recently been shown to 
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identify 16 – 22% of patients as being ‘low risk’ (GBS ¼ 0;) who could be safely managed as 
outpatients.(8)  
Table 2: Glasgow Blatchford score (GBS) 
 
Admission risk marker Score value 
Blood urea (mmol/L) 
  6.5–8 2 
 8–10 3 
 10–25 4 
 >25 6 
Hb (g/L) for men 
  120–130 1 
 100–120 3 
  <100 6 
Hb (g/L) for women 
  100–120 1 
  <100 6 
Systolic blood pressure (mmHg) 
  100–109 1 
 90–99 2 
  <90 3 
Pulse ≥100/minute 1 
History/co-morbidities 
  Presentation with melaena 1 
 Presentation with syncope 2 
 Hepatic disease* 2 
 Cardiac failure
†
 2 
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*Known history of or clinical/laboratory evidence of chronic or acute liver disease 
†
Known history of or clinical/echocardiographic evidence of cardiac failure 
 
In addition to the GBS, other non-endoscopic scores have been developed including the Cambridge score 
(9) and an American score based on an aritﬁcial neural network (ANN).(10) 
The Cambridge score requires 14 clinical and laboratory variables and identiﬁes only 6% low-risk 
patients who may be suitable for outpatient management. Partly for these reasons it has not been 
externally validated or widely adopted. The ANN score requires 20 variables in addition to computer 
software for analysis, which makes it less attractive to busy clinicians.  
A summary of the main scores is shown in Table 3   
 
Table 3: Summary of main risk scoring systems for UGIH 
 
Score (ref.) 
Endoscopy 
required? 
No. of 
variables 
Suitable for 
unselected 
UGIH patients? 
Validated for early 
patient discharge? 
Rockall
4
 Yes 6 Yes Yes 
Admission' Rockall
4
 No 4 Yes Yes 
Glasgow Blatchford
5
 No 5 Yes Yes 
Cambridge
8
 No 14 Yes No 
ANN
9
 No 20 No No 
 
Recommendations from the SIGN guideline, the international consensus guideline and the UK national 
audit include early risk assessment of patients presenting with UGIH.(10) (12) The 2008 SIGN guideline 
suggested the use of the admission Rockall score, but was published before several recent papers directly 
comparing the GBS and admission Rockall scores, while the 2010 international guidelines recognized the 
recent favorable comparisons for the GBS. 
A recent national UK audit of 6750 patients with UGIH has revealed that only 52% hospitals had an out-
of-hours endoscopy service and only 50% patients received endoscopy within 24 hours of 
presentation.(13)Therefore many lower risk patients may stay in hospital longer than necessary, when 
outpatient management may be appropriate    
No study has been able to demonstrate that early endoscopy leads to a reduction in mortality. 
Nevertheless the BSG guidelines along with others emphasise the importance of endoscopy within 24 h of 
presentation particularly for high risk patient (14) (15) 
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While several scores are useful in identifying low-risk patients who may be suitable for early discharge, 
they appear less helpful in differentiating medium and higher risk patients who may require emergency 
endoscopy or high dependency/intensive care management, However the sensitivity of these scores is 
probably more important than the specificity, as the clinician does not want to mistakenly label a higher 
risk patient as ‘low-risk’ and possibly discharge them early. 
GBS is equivalent to both the full and admission Rockall scores in predicting death and superior to both 
in predicting need for blood transfusion. The GBS is similar to the full Rockall score and superior to the 
admission Rockall score in predicting need for endoscopic therapy or surgery.(16)  
A recent data from London also showed The GBS but not the pre-endoscopy Rockall score identifies 
patients with upper gastrointestinal bleeding who may be suitable for outpatient management, therefore 
potentially allowing for more efficient use of hospital resources.  (17)  
A recent studiy from Hong Kong have shown that The Blatchford score is more useful for predicting low-
risk patients who do not need therapeutic endoscopy and who may be suitable for outpatient management. 
A threshold of 0 for low risk should be used. The Rockall score is not helpful in predicting the presence 
of low-risk lesions.(18). However the proportion of patients fulfilling the GBS low-risk criteria in this 
Chinese study was lower than the published UK figures, which may be due to differences in patient 
populations and health-care delivery 
One study assessed the three main endoscopy-based scores and found that the full Rockall was superior to 
the Cedars Sinai and Baylor scores, particularly for lower risk patients. In this study, all scores were 
better at predicting mortality than re-bleeding, (19) 
A publication from USA suggested that  An GBS of 1 or less  exhibit a low chance of having lesions that 
benefit from therapeutic endoscopy and have a low risk of rebleeding (5%) and mortality (0.5%) SO IT 
HAS  a 100% negative predictive value for re-bleeding or death, or need for intervention, 
respectively.(20)   
Recent recommendations from a consensus panel in Asia (21) suggest using the GBS to triage patients for 
more-intensive therapy. Other studies have suggested the complete Rockall score is more accurate. 
 The key point is that the selection of a specific scoring system is less important than using some method 
to predict which patients need early endoscopy and vigorous therapy. Both the GBS and pre-endoscopy 
Rockall scores can achieve this goal. All three systems are based on clinical measures that reflect the 
volume of bleeding and the hemodynamic status of the patient. The complete Rockall score has the 
advantages of adding the presence of endoscopic stigmata, which are the best predictors of rebleeding, 
and allowing simultaneous endoscopic therapy that can reduce that risk for rebleeding. A low score and 
decision for outpatient therapy do not obviate the need for outpatient endoscopy at the earliest possible 
time 
 
Conclusion: 
There is a growing body of evidence and consensus opinion to recommend the early use of risk 
stratification scores for patients presenting with UGIH.  
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Whilst a score for optimal sensitivity and specificity could be calculated, in practice the clinician will err 
towards sensitivity at the cost of specificity. Therefore, the scores are best used to identify low risk 
patients for non-admission or early discharge. As previously reported by our group, a GBS score of zero 
had 100% sensitivity for intervention or death, but there were interventions and a death amongst those 
with an admission Rockall score of zero.  
The GBS appears superior to the admission Rockall score for early non-endoscopic risk assessment and 
identifies low-risk patients in whom admission can be safely avoided. All scores seem to perform less 
well among patients at higher risk. Further studies are required to compare scoring systems in different 
populations and further clarify their role in clinical practice. 
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